Home > SWOT Analysis > Celgene (CELG) SWOT Analysis

Celgene (CELG) SWOT Analysis Profile

Celgene Corporation is a biopharmaceutical company engaged in the development and marketing of innovative therapies to treat cancer and immune-inflammatory related diseases, primarily in Europe and the United States. The company also creates medications for attention deficit hyperactivity disorder, psoriasis, arthritis, and fibrotic diseases, many of which are in preclinical trials. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 17

Threats + Weaknesses = 14

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties. The ability to capitalize on opportunities get rewarded with higher profits and lower costs. Maintaining strengths can help maintain high profits and low costs.